Mechanism of Action 5-Amino-1MQ selectively inhibits nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular methylation and NAD+ metabolism, making it a widely referenced tool in enzymatic and epigenetic research models
Searches of clinicaltrials.gov for BPC-157 return only a small number of registered studies, predominantly observational or compounded-product registries rather than randomized interventional trials with peer-reviewed protocols and pre-registered outcome measures
administered BPC 157 (10mcg/kg or 10 ng/kg) orally, in drinking water (12 ml/rat/day) or intraperitoneally (once daily, first application 30 min following surgery to test its effects on short bowel syndrome in rats, observing the effectiveness of both forms of administration [24]
Researchers propose that the peptide's brief presence is sufficient to trigger a cascade of gene expression changesincluding activation of transcription factors c-Fos, c-Jun, and Egr-1that initiate self-sustaining healing processes well beyond the peptide's physical presence
Cell-free gene expression: An expanded repertoire of applications
The fEPSP slope actually showed significant decreases following application of IGF-1 DES in combination with genistein